K213491 is an FDA 510(k) clearance for the Universal Pilot Guidance Instrument System. Classified as Orthopedic Stereotaxic Instrument within the OLO classification (a category covering orthopedic stereotaxic and surgical navigation instruments), Class II - Special Controls.
Submitted by Ctl Medical Corporation (Addison, US). The FDA issued a Cleared decision on May 12, 2022 after a review of 192 days - an extended review cycle.
This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 882.4560 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.
View all Ctl Medical Corporation devices